Bayesian Capital Management’s Endo International plc ENDP Stock Holding History

Bayesian Capital Management’s Portfolio ENDP Stock Details ENDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-16,701	Closed	-$78K	–	1035
2019 Q4	$78K	Sell	16,701 -35,399	-68%	-$158K	0.01%	568
2019 Q3	$167K	Buy	52,100 +500	+1%	+$1.61K	0.03%	458
2019 Q2	$213K	Buy	51,600 +9,286	+22%	+$58.6K	0.04%	427
2019 Q1	$340K	Sell	42,314 -7,400	-15%	-$69.6K	0.07%	365
2018 Q4	$363K	Sell	49,714 -34,486	-41%	-$473K	0.07%	357
2018 Q3	$1.42M	Buy	+84,200	New	+$1.2M	0.23%	112
2018 Q1	–	Sell	-14,700	Closed	-$114K	–	881
2017 Q4	$114K	Buy	+14,700	New	+$110K	0.02%	512
2017 Q3	–	Sell	-17,000	Closed	-$190K	–	691
2017 Q2	$190K	Buy	+17,000	New	+$200K	0.07%	374
2016 Q4	–	Sell	-36,600	Closed	-$737K	–	740
2016 Q3	$737K	Buy	+36,600	New	+$728K	0.48%	56

Other funds holding ENDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bayesian Capital Management's ENDP Position: Q1 2020 in Review

Bayesian Capital Management sold out of Endo International plc (ENDP) in Q1 2020, closing a stake of 16,701 shares — an estimated $78K sold.

Bayesian Capital Management first reported a position in ENDP in Q3 2016 and held it in 9 quarters. The position peaked at $1.42M in Q3 2018. 185 funds tracked by Wall St. Rank hold ENDP as of Q1 2020.

Bayesian Capital Management reported no remaining Endo International plc position as of Q1 2020 after selling out during the quarter.
Bayesian Capital Management sold 16,701 Endo International plc shares in Q1 2020, an estimated $78K.
Bayesian Capital Management first reported a position in Endo International plc in Q3 2016 and held it in 9 quarters.
Bayesian Capital Management's Endo International plc position peaked at $1.42M in Q3 2018.
185 funds tracked by Wall St. Rank held Endo International plc as of Q1 2020.

Based on Bayesian Capital Management's 13F filing for Q1 2020, filed 15 May 2020.